Ruthenoleuton
Ruthenoleuton is a 5-lipoxygenase (5-LOX) inhibitor with an IC50 of 3.49 μM and a Ki of 0.80 μM. Ruthenoleuton has antioxidant activity and can be used in the research of inflammatory diseases[1].
Product Specifications
UNSPSC
12352100
Target
Lipoxygenase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Inflammation/Immunology
Smiles
[][Ru][].CC(c1cccc1)N(O)C(N)=O.c2cccc2
Molecular Formula
C13H16N2O2Ru
Molecular Weight
333.35
References & Citations
[1]Navarrete E, et al. Development of Ferrocenyl and Ruthenocenyl Zileuton Analogs with Enhanced Bioactivity toward Human 5-Lipoxygenase: Innovation in Drugs for Inflammatory Diseases. Inorg Chem. 2025 Feb 24;64 (7) :3495-3505.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
5-LOX
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
221275-01 50 µL
CaMKII alpha, phosphorylated (T286) (Calcium/calmodulin-Dependent Protein Kinase Type II Subunit alpha, CaM Kinase II Subunit alpha, CaMK-II Subunit alpha, CAMK2A, CAMKA, KIAA0968, CaMK2-a, CaMK2a, CaMK-2a) discontinued
Ask
View Details 
221275-02 100 µL
CaMKII alpha, phosphorylated (T286) (Calcium/calmodulin-Dependent Protein Kinase Type II Subunit alpha, CaM Kinase II Subunit alpha, CaMK-II Subunit alpha, CAMK2A, CAMKA, KIAA0968, CaMK2-a, CaMK2a, CaMK-2a) discontinued
Ask
View Details MBS1329838-01 0.02 mg (E-Coli)
Recombinant Shigella sonnei o-succinylbenzoate synthase (menC)
Ask
View Details MBS1329838-02 0.02 mg (Yeast)
Recombinant Shigella sonnei o-succinylbenzoate synthase (menC)
Ask
View Details